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ABSTRACT: We present ONIOM calculations using density
functional theory (DFT) as the high and AM1 as the medium
level that explore the abilities of diﬀerent hexapeptide sequences to
terminate the growth of a model for the tau-amyloid implicated in
Alzheimer’s disease. We delineate and explore several design
principles (H-bonding in the side chains, using antiparallel
interactions on the growing edge of a parallel sheet, using all-D
residues to form rippled interactions at the edge of the sheet, and
replacing the H-bond donor N−H’s that inhibit further growth) that
can be used individually and in combination to design such peptides
that will have a greater aﬃnity for binding to the parallel β-sheet of
acetyl-VQIVYK-NHCH3 than the natural sequence and will prevent
another strand from binding to the sheet, thus providing a cap to the
growing sheet that arrests further growth. We found peptides in which the Q is replaced by an acetyllysine (aK) residue to be
particularly promising candidates, particularly if the reverse sequence (KYVIaKV) is used to form an antiparallel interaction with
the sheet.

■

INTRODUCTION

In this paper, we explore methods of interrupting these
cooperative interactions by designing peptides that can bind
selectively to the growing β-sheet to prevent attachment of
further VQIVYK segments, thus terminating the growth of the
amyloid structure. To be eﬀective, such peptides must bind
more strongly to the growing amyloid sheet than to the native
VQIVYK and disrupt continued growth by inhibiting the
further binding of native VQIVYK. We evaluate several
strategies that lead to design principles that enhance the
interaction with the amyloid β-sheet then combine these to
develop possible eﬀective methods for disrupting further
growth of the β-sheet structure: (1) removing the H-bonding
donors on the amides by derivatizing with alkyl or other groups
on these positions on either the backbone amido or the side
chain of the Q or both and (2) changing Q to acetyllysine (aK),
which will form an H-bond to Q that is sterically oriented to
prevent the Q of another VQIVYK from continuing the
stabilizing H-bonding chain.
We present ONIOM (B3LYP/AM1) calculations on the
interaction energies and enthalpies of several hexapeptides
(capped with acetyl and NHCH3) with a sheet containing three
strands of VQIVYK. We chose the three-stranded sheet as a
practical balance between a sheet that is suﬃciently large to
exhibit H-bond cooperativity between the Q’s yet suﬃciently

Amyloid ﬁbrils can be associated with several diseases, either as
a cause or a symptom. In Alzheimer’s disease, two diﬀerent
kinds of misfolding/aggregation occur: (1) plaques of
aggregated β-sheet-like proteins form, and (2) the protein,
tau, which normally promotes aggregation of tubulin to form
the natural tubular material of neuron ﬁbrils, instead forms
other aggregates, which results in neurons’ losing their neuron
ﬁbrils and, thus, their function.1
Amyloid ﬁbrils result from the association of multiple
individual peptide units into large clusters. The formation of
these ﬁbrils resembles a crystallization in one dimension. Short
peptides containing the key sequences of 4−6 residues
necessary for the formation of several amyloids have been
crystallized and subsequently used to seed amyloid formation
from the relevant proteins.2 We have reported density
functional theory (DFT) calculations that show how the
glutamine (Q) residues in one of these peptide sequences
306
VQIVYK311, essential for amyloid formation from the
protein, tau, contribute to the tendency of a small peptide of
this sequence to form crystals and the tendency of tau to form
amyloids.3,4 These calculations illustrate the importance of
cooperative H-bonding, particularly between the amides
contained in the side chains of the Q’s, to the formation of
stable amyloid structures.
© 2014 American Chemical Society
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small to allow the multiple calculations with complete
geometrical optimization (often of several diﬀerent conformations of each species) that this work requires.
Previous experimental studies based upon sheet-forming
propensities have suggested that peptides containing proline
could inhibit growth of some β-sheets, including the Aβ
amyloid that is also associated with Alzheimer’s disease.5−7 We
have recently found that P residues when substituted for A’s in
certain positions of AAAAAA slightly enhance the interaction
with the parallel (but not the antiparallel) all-AAAAAA sheet.8
Additional bonding of another AAAAAA would be prevented
by the lack of an H-bond donor on the P residue.

The counterpoise correction (CP) for basis set superposition
error (BSSE) has been applied to all interaction energies and
enthalpies using the single point a posteriori procedure26−29
because optimization of such large structures on a CP-corrected
surface30 would have been too computationally intensive, and
the ONIOM and CP-optimization cannot be performed
simultaneously using the Gaussian09 program. Balabin has
recently emphasized the importance of BSSE correction for
biochemical and other calculations.31,32
Because the model for these calculations is solid-state (the
amyloids are not soluble), no solvation energies have been
calculated, and the lysine residues are assumed to be neutral to
avoid proximate positive charges.

■

■

METHODS
We used the ONIOM9,10 method as programmed in the
Gaussian0911 suite of computer programs. ONIOM divides the
system into up to three segments, which can be treated at
diﬀerent levels of calculational complexity. Thus, one can treat
the essential part of the system at the high level while the less
critical parts of the system might be calculated at the medium
or low level. For this study, we used only two levels (high and
medium). We treated the backbones of the peptides
(equivalent to a corresponding peptide containing only
glycines) and the glutamine (Q) residues at the high level,
with only the side chains that distinguish the other diﬀerent
residues from that of glycine at the medium level. The high
level used hybrid DFT methods at the B3LYP/D95(d,p) level.
This method combines Becke’s 3-parameter functional12 with
the nonlocal correlation provided by the correlation functional
of Lee, Yang, and Parr.13 In the ONIOM method, there are
unsatisﬁed valences in the high level at the interface between it
and the medium level. These valences were satisﬁed by using
the default method of capping them with a hydrogen atom in
the direction of the connecting atom in the medium level with a
C−H distance of 0.723 886 times the C−C distance. We used
the AM114 semiempirical molecular orbital method for the
ONIOM medium level. We have shown B3LYP to be
preferable to several functionals, speciﬁcally parametrized to
treat dispersion for calculations on peptides.15
We optimized all geometries in all internal degrees of
freedom and performed vibrational calculations to ensure the
geometries are true minima on the potential energy surfaces
(PESs) for sheets containing up to ﬁve strands and to obtain
the vibrational frequencies used to calculate the enthalpies at
298 K. We have found small imaginary frequencies for some of
the calculations. We have previously encountered this problem,
which appears to be related to the ﬁneness of the grid used in
the DFT procedure. As in the past, we have corrected the
enthalpies by RT, which would be appropriate for a low
frequency.16
In a previous study of ﬁve 17-amino-acid peptides,17 we
found little diﬀerence in relative energies between this
procedure and another in which the side chains (in this case,
the methyls) were subsequently optimized using DFT, with the
(previously optimized) peptide chain held ﬁxed. The current
procedure also gave relative energies that agreed well with
complete DFT optimizations for a series of ﬁve small 310-helical
peptides.18 We have used this procedure with success for
several previous studies of peptide structures,3,4,16,18−24 and
have shown it to compare favorably with other functional/basis
set combinations for calculations on the gas phase water
dimer.25

RESULTS
We investigated several types of peptides to test their aﬃnities
for a three stranded VQIVYK parallel β-sheet, which we used as
a model for the growing amyloid. Although the amyloid sheet
consists of parallel strands, there is no reason to exclude
antiparallel interactions of the capping strand with the
proximate strand of the amyloid, so we considered both
parallel and antiparallel interactions. In addition, we considered
both pleated and rippled sheets where appropriate. Rippled
sheets were proposed by Pauling and Corey for interactions
between enantiomeric peptide strands.33 Both of these
conformations were found for polyglycine sheets because
glycine (both from experiment34 and theory35) is enantiomorphic, but only pleated structures were found for (all Lpolyalanine) polyalanine sheets.4 The hexapeptides used can be
categorized into several classes (see Table 1): (A) A simple
Table 1. Six Categories of Hexapeptides Considered As Caps
for for a Three-Stranded VQIVYK Parallel β-Sheet
A
B
C
D
E
F

AAAAAA a useful standard
KYVIQV the reverse sequence of VQIVYK
(all-D) TLKIVW a peptide reported to inhibit amyloid growth
VQIVYKs where the Q have one or more N−H’s derivatized
VQIVYKs where the backbone N−H’s are derivatized
modiﬁcations of VQIVYK or KYVIQV with Q replaced by aK

hexaalanine that can interact with the amyloid model in four
diﬀerent combinations at each of the top and bottom positions
(see Figure 1 for deﬁnitions of top and bottom), parallel and
antiparallel combined with pleated and rippled sheets. (B) The
reverse sequence of the amyloid hexapeptide, KYVIQV, again
binding in both parallel and antiparallel forms and from both
top and bottom. C) The hexapeptide (all-D) TLKIVW, one of
several recently designed peptides and tested by Eisenberg et al.
to disrupt the amyloid by impeding what they characterize as
the “dry zippers” that they believe provide the favorable
interactions between the β-sheets of the amyloids.36 For this
reason, we explored several all-D peptides that can form rippled
sheets (including all-D VQIVYK). (D) Various VQIVYKs in
which the Q’s have one or two methyl or methoxy substituents
in place of the N−H’s on the side chain, which can bind only to
the top of the amyloid model. All-D peptides have the additional
advantage of increased stability to normal peptide degradation.
(E) Two forms of VQIVYKs in which every second backbone
N−H is methylated or otherwise substituted (in one, the ﬁrst,
third’ and ﬁfth; in the other, the second, fourth, and sixth). (F)
Modiﬁcations of VQIVYK and KYVIQV, in which Q is
replaced by acetyllysine (aK). Of those that have one or more
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Figure 1. Structure of a three-stranded β-sheet of acetyl-VQIVYK−NHCH3 with capping strands of two modiﬁed peptides that are appropriately
methylated to prevent further growth of the β-sheet form at the top and bottom. The arrows indicate the methyls. The peptide backbones are
depicted as tubes; the Q-side chains, as ball and stick; and the other side chains, as wire-frame. Note that the methylated peptides are methylated in
diﬀerent positions.

peptide can be diﬀerent from the others, so the optimized
geometry of this peptide (hence, its distortion energy) might be
substantially diﬀerent for each case. The structures of the
extended strands contain slightly cooperative C5-intrastrand
cyclic H-bonds, as previously reported.37−41 The interaction
energy of the capping peptide with the sheet will be a
combination of ΔEHB and ΔEdist, whose sum equals the energy
of interaction with respect to the optimized cap and sheet
(ΔEint) with respect to the optimized capping strand. We also
include the enthalpies of interaction (ΔHint) of the optimized
capping peptide with the optimized sheets in the tables. Since
ΔEHB and ΔEdist, involve diﬀerences in energies of species that
are not minima on the potential energy surfaces, frequencies
and ΔHHB and ΔHdist’s would not be meaningful.
Because ΔEint and ΔHint depend upon both ΔEHB and ΔEdist,
a favorable ΔHint could be due to a small ΔEdist, a large negative
ΔEHB, or both. Because each capping peptide has a diﬀerent
optimized structure, which may change in a diﬀerent way upon
substitution, we combine two criteria to ascertain which

N−H’s replaced by N−CH3, some can only bind to the top;
others, the bottom of the amyloid model. We compared these
with the normal VQIVYK peptide attached in the normal
parallel-pleated manner and in three alternate conformations
(parallel-rippled and antiparallel-pleated and -rippled). We
considered 33 diﬀerent peptide interactions at the top and 28 at
the bottom, in total, in addition to the “normal” VQIVYK
sequence.
In addition to determining the ΔHint’s, we decompose the
energetic interactions of the capping peptide with the sheets
into the H-bonding and distortion energies, as we have recently
done in our studies of polyglycine35 and polyalanine4 β-sheets.
We deﬁne the H-bonding energies (ΔEHB) as the interactions
between the capping strand and the sheet frozen in the
geometries of the optimized capped sheet, and the distortion
energies (ΔEdist), as the energies required to change the
geometry of the relaxed extended capping strand and the
relaxed three-stranded sheet to those assumed in the optimized
capped sheet. In the cases that we treat here, the capping
3328
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Table 2. Relevant Energies and Enthalpies for the Most Eﬀective Capping Peptidesa
ΔEdist
ΔHint

capping peptides
KYVIacKV MMMM
VQIVYK Q2M 1c7
KYVIacKV
KYVIQV
AQAAAA MMMM
VQIVYK HMHH 2
VQIVYK QM trans 1c7

S2
S5
S7
S4
S13
S15
S19

VQIVYK
KYVIacKV MMM
VQIVYK HMM
VQIVYK HMH
KYVIacKV
KYVIQV
VQIVYK

AP
P
AP
AP
P
P
P
P

S36
S39
S43
S44
S40

AP
P
P
AP
AP
P

Top
−38.5
−32.8
−32.3
−30.4
−29.6
−29.5
−28.5
Natural Amyloid
−28.1
Bottom
−37.5
−33.7
−32.2
−31.7
−29.2
Natural Amyloid
−28.1

ΔEHB

cap

sheet

ΔEint

−54.8
−53.3
−55.3
−55.8
−54.1
−53.5
−53.1

5.9
10.9
13.0
16.1
15.2
14.8
15.2

7.2
5.3
6.6
5.6
5.3
5.3
5.3

−41.7
−37.2
−35.7
−34.0
−33.6
−33.3
−32.6

−53.0

15.6

5.3

−32.0

−56.2
−53.2
−53.6
−55.0
−53.8

10.4
9.9
12.0
14.7
15.7

5.4
5.8
5.5
5.1
5.0

−40.4
−37.6
−36.1
−35.2
−33.1

−53.2

16.1

5.1

−32.0

Those with more favorable ΔHint and ΔEHB than the natural amyloid sequence (in kcal/mol). The following abbreviations are used: AP
(antiparallel), P (parallel); QM, Q2M (one or 2 methyls in the Q side chain); sequences of Ms and H’s indicate methylated backbone N−H’s starting
from the N-terminus. All structures form pleated sheets. The designation of the capping peptide is followed by the ﬁgure number in the SI that
corresponds to the capped sheet.

a

Figure 2. Structure of a three-stranded β-sheet of acetyl-VQIVYK-NHCH3 capped with KYVIaKV (AP) at the top. The peptide backbones are
depicted as tubes; the Q and aK side chains, as ball and stick; and the other side chains, as wire-frame.

that is methylated to prevent further H-bonding. These can
form only H-bonds, to either the top or the bottom. Two of
these peptides, AP KYVIQV and AP KYVIaKV, can form Hbonds to either the top or bottom of the sheet. The former
should not be useful to block continued amyloid formation
because a normal VQIVYK could simply bind to it to continue
the parallel sheet of VQIVYKs with one antiparallel

capping peptides bind preferentially to the three-stranded
sheet: ΔHint and ΔEHB. If both of these indicate a preference,
the preferences indicated by our calculations become more
secure. Table 2 contains those peptide caps that meet both
criteria. This table provides data for seven peptides that bind to
the top and ﬁve that bind to the bottom better than the natural
amyloid sequence VQIVYK. Most contain at least one N−H
3329
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Figure 3. Structure of a three-stranded β-sheet of acetyl-VQIVYK-NHCH3 capped with KYVIaKV (AP) at the bottom. The peptide backbones are
depicted as tubes; the Q and aK side chains, as ball and stick; and the other side chains, as wire-frame.

β-sheets. We have previously shown this in two earlier
reports on these sheets3,4 and another on α-helices where
every fourth residue is Q and the others are all A.23
Several experimental reports support this view. A capped
QQQ tripeptide shows CO stretches of the side chains
consistent with H-bonding.42 Several short peptide
sequences that are essential to amyloids and have been
crystallized involve Q’s whose side chains H-bond to
each other (as well as, N’s which also do this).2 Long
sequences of Q’s in peptides lead to amyloid-like
structures.43,44 Thus, we consider H-bonding to Q by a
peptide side chain to be an important design principle.
We have considered peptides in which the Q is replaced
by aK because this residue can provide a similar
cooperative H-bond.
(B) Intermolecular antiparallel β-sheets are more stable than
their parallel counterparts for simple structures such as
acetylA6NH2 and acetylG6NH2, according to our
previous calculations.4,35 Hence, we would expect AP
interaction between the sheet and the cap to probably
enhance the aﬃnity of the cap for the sheet.
(C) Rippled sheets can form only from alternating strands
containing residues of opposite chiralities. Because we
deal only with capping peptides, the rippled interaction
would occur only between the cap and the proximate
strand. One of the polymorphs of polyglycine I (which is
actually two polymporphs) forms rippled sheets.34
Glycine is the only natural residue that can do this
because it is enantiomorphic. Our calculations on
polyglycine suggest the rippled and pleated sheets have
similar energies but that the vibrational contribution to
the enthalpy is lower for the rippled sheet.35 Because allD TLKIVW has been reported to be useful for arresting
amyloid growth,36 we considered rippled interactions to
see if they provided better binding.
(D) Derivitizing one or more N−H’s to methyls or other
groups (here, methoxyl) will prevent H-bonding by the
donor (as already noted), but it can also aﬀect (1) the

interruption. However, AP KYVIaKV assumes a geometry that
would prevent the continued cooperative H-bonding chain of
Q side chains essential to the stability of the amyloid. From the
geometry of the capped sheet in Figures 2 and 3, one sees the
inaccessibility of the H-bonding CO or N−H of the aK
amide group to further H-bonding from the Q’s. The peptides
in Table 2 with the strongest interactions at both the top and
bottom interact in the AP fashion. Our previous reports have
shown that AP interactions are more energetically favorable
than P interactions for β-sheets of both hexaalanines4 and
hexaglycines.35
Table 3 contains capping peptides with ΔHint’s that are more
favorable than that for VQIVYK but ΔEHB’s that are less
favorable. For these, the lower ΔEdist’s compensate for their
unfavorable ΔEHB’s. This table contains several peptides that
form rippled sheets. These contain all-D residues, as rippled
interactions occur between strands containing residues of
opposite chirality. Table 4 lists those peptides for which both
ΔHint and ΔEHB are less favorable than those of VQIVYK. As in
previous optimizations of alanine β-sheets, we have often found
C7 cyclic H-bonding near the termini of the sheets.4,16 We have
indicated structures containing a C7 interaction in the relevant
entries of the tables.

■

DISCUSSION
The principal goal of this work is to provide a rational approach
to arresting the growth of tau amyloid ﬁbrils and to extend the
principle to amyloid formation in general. As mentioned above,
we see this as a problem that involves primarily onedimensional crystal growth. We designed the capping peptides
that we have considered for two purposes: (1) to ﬁnd peptides
that would bind more tightly than VQIVYK and (2) to test the
principles that could be used for such a design. The peptides
with the highest aﬃnities for the VQIVYK sheet demonstrate
these principles separately and in combination with each other.
We begin by discussing these principles:
(A) Cooperative H-bonding between the Q side chains
provides an important stabilization to parallel VQIVYK
3330
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Table 3. Relevant Energies and Enthalpies for the Possibly Eﬀective Capping Peptidesa
ΔEdist
ΔHint

capping peptides
VacKIVYK MMMM
TLKIVW 1c7
R TLKIVW
VQIVYK MMMM
VQIVYK Q2OM
R TLKIVW1c7
Pl VQIVYK HMMM
VacKIVYK
Pl AAAAAA
R AAAAAA 1c7
VQIVYK HHMH
VQIVYK MHHH
TLKIVW
VQIVYK MHHM
amyloid VQIVYK

S1
S3
S6
S9
S8
S12
S11
S10
S14
S16
S17
S20
S24
S21

P
AP
AP
P
P
P
P
P
AP
AP
P
P
P
P
P

VQIVYK MMM
VacKIVYK MMM
VQIVYK Tbut Tbut Tbut
R TLKIVW
TLKIVW
VQIVYK MHH
VQIVYK FFF
AQAAAA MMM
VQIVYK HHM
TLKIVW
R AAAAAA
VacKIVYK
AAAAAA
R VQIVYK
amyloid VQIVYK

S35
S37
S38
S41
S42
S45
S47
S46
S49
S50
S51
S48
S52
S55

P
P
P
AP
AP
P
P
P
P
P
AP
P
AP
AP
P

Top
−38.9
−34.0
−33.4
−29.6
−30.9
−30.0
−29.9
−29.8
−29.8
−29.7
−28.8
−28.8
−28.3
−28.3
−28.1
Bottom
−37.1
−36.0
−35.2
−33.2
−32.6
−31.2
−30.5
−30.5
−30.0
−29.9
−29.8
−29.4
−29.4
−28.7
−28.1

ΔEHB

cap

sheet

ΔEint

−50.1
−48.1
−46.1
−51.3
−51.7
−46.7
−52.2
−52.2
−43.6
−43.1
−53.0
−52.1
−45.0
−51.4
−53.0

5.0
4.7
5.0
11.8
11.3
6.2
13.4
12.6
6.3
6.0
14.9
14.6
7.1
14.4
15.6

3.1
5.4
4.4
4.9
5.4
6.8
5.1
5.9
4.0
3.8
5.3
5.0
6.1
5.0
5.3

−42.0
−38.0
−36.6
−34.5
−35.1
−33.6
−33.7
−33.7
−33.4
−33.3
−32.8
−32.5
−31.8
−32.0
−32.0

−52.6
−51.6
−51.0
−44.2
−45.2
−52.5
−51.9
−52.0
−52.6
−43.7
−43.1
−52.7
−44.9
−52.4
−53.2

6.2
6.7
5.8
3.9
4.9
12.4
13.2
12.7
13.6
5.8
5.7
13.6
7.3
14.0
16.1

5.5
5.4
6.0
3.7
3.9
5.0
4.4
4.7
5.2
4.3
4.0
5.3
4.5
6.2
5.1

−40.9
−39.5
−39.2
−36.6
−36.3
−35.1
−34.4
−34.6
−33.8
−33.6
−33.4
−33.8
−33.1
−32.2
−32.0

Those with more favorable ΔHint but not ΔEHB than the natural amyloid sequence (in kcal/mol). The following abbreviations are used: AP
(antiparallel), P (parallel); QM, Q2M (one or 2 methyls in the Q side chain); QOM, Q2OM (one or two methoxyls on the Q side chain) sequences of
Ms and H’s indicate methylated backbone N−H’s starting from the N-terminus. All structures form pleated sheets except those marked with an “R”,
which are rippled sheets. The capping peptides of the rippled sheets contain all-D amino acid residues. The designation of the capping peptide is
followed by the ﬁgure number in the SI that corresponds to the capped sheet.
a

tertiary butyl (t-bu) in as much detail as those of methyl, they
all reduce the magnitude of ΔEHB. All substituents on the
backbone N−H’s tend to reduce the ΔEdist of the cap,
sometimes quite signiﬁcantly. For example, three methyls on
the bottom cap reduce ΔEdist by 9.9, whereas 3 t-bu’s reduces it
by 10.8 kcal/mol. Thus, the eﬀects of substituting the N−H’s
with other entities does not appear to be primarily electronic.
Rather, they sterically induce the strand into a conformation
more favorable for binding to the sheet. The only exception to
this trend, a trans methoxyl substitution on the Q side chain
(rather than the backbone), increases ΔEdist by only 0.2 kcal/
mol. We note that the TLKIVW and AAAAAA caps have some
of the lowest ΔEdist values.
The ΔHint’s with AAAAAA at both the top and bottom are
more favorable than VQIVYK for the AP, but less favorable for
the P interaction. The ΔEHB’s are less favorable because of the
lack of the H-bond between the side chains, so the lower
ΔEdist’s cause the favorable enthalpy, which is consistent with
the earlier ﬁnding that the AP AAAAAA sheets are more
favorable than the P sheets.4 The rippled APs with the all-D
version of this peptide are not signiﬁcantly diﬀerent from the

strengths of the H-bonds to the acceptor (CO) and
(2) the relaxed geometry (thus, the ΔEdist) of the strand.
All of those peptides that bind better than VQIVYK by both
the ΔHint and the ΔEHB criteria (those of Table 2) have either a
Q or an aK that can H-bond to the chain of H-bonding Q’s in
the amyloid. On the other hand, all but three of the peptides
that have the least favorable interactions (those listed in Table
4) lack the H-bond to the side chain of the Q. Parallel VQIVYK
QOM (both cis trans) and VQIVYK HHHM are the exceptions.
When the VQIVYK fragment forms an AP pleated or a P
rippled interaction (with all-D residues), the Q on the capping
peptide faces the opposite side of the sheet from the others.
The three exceptions suggest that the substituent eﬀects of
methoxyl on Q and one methyl on the last backbone N−H
from the N-terminus weaken the H-bonds to the CO’s of
their amide groups.
Interestingly, the methyl substituent eﬀects upon ΔEHB for
parallel VQIVYK caps vary between enhancement by 0.5 to
reduction of 1.2 kcal/mol per methyl, which suggests them to
be minor and diﬃcult to predict. Although we have not
examined the substituent eﬀects of ﬂuoro, methoxyl, and
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Table 4. Relevant Energies and Enthalpies for the Least Eﬀective Capping Peptidesa
ΔEdist
ΔHint

capping peptides
AAAAAA MMMM
VQIVYK HHHM
VQIVYK QOM trans 1c7
VQIVYK QOM 1c7
AAAAAA 2c7
VQIVYK FFFF
VQIVYK
R VQIVYK 1c7
KYVIQV 2c7
R KYVIQV 2c7
R AAAAAA 1c7
R KYVIQV 2c7
R VQIVYK

S23
S25
S27
S26
S28
S29
S30
S32
S18
S22
S33
S31
S34

P
P
P
P
P
P
AP
AP
P
AP
P
P
P

R TLKIVW
VQIVYK
AAAAAA MMM
AAAAAA
R KYVIQV
R KYVIQV
KYVIQV
R AAAAAA 1c7
R VQIVYK

S57
S59
S58
S60
S56
S53
S54
S61
S62

P
AP
P
P
AP
P
P
P
P

Top
−27.9
−27.6
−27.0
−26.9
−26.8
−26.8
−26.6
−26.2
−25.3
−25.2
−24.9
−22.4
−21.1
Bottom
−27.6
−26.8
−26.8
−25.9
−25.5
−25.2
−25.0
−24.8
−20.2

ΔEHB

cap

sheet

ΔEint

−45.5
−52.1
−52.7
−52.4
−45.7
−48.8
−48.4
−46.7
−48.0
−46.2
−44.1
−46.2
−45.5

8.9
15.4
16.3
15.8
9.6
14.1
13.3
13.3
13.6
13.8
9.8
14.3
15.0

4.6
5.2
5.3
5.3
5.3
4.4
5.2
4.3
5.3
4.1
5.5
6.4
5.9

−31.9
−31.5
−31.1
−31.2
−30.9
−30.3
−29.9
−29.1
−29.1
−28.3
−28.9
−25.5
−24.5

−42.6
−50.4
−44.5
−44.1
−45.2
−49.8
−50.2
−43.1
−44.7

6.2
14.8
9.5
9.9
12.7
15.0
16.2
9.2
16.0

5.1
5.3
4.4
4.2
4.1
5.7
5.0
5.2
5.2

−31.3
−30.3
−30.6
−30.0
−28.4
−29.1
−28.9
−28.7
−23.6

Those with less favorable ΔHint and ΔEHB than the natural amyloid sequence (in kcal/mol). The following abbreviations are used: AP (antiparallel),
P (parallel); QOM, Q2OM (one or two methoxyls on the Q side chain) sequences of Ms and H’s indicate methylated backbone N−H’s starting from
the N-terminus. All structures form pleated sheets except those marked with an “R”, which are rippled sheets. The capping peptides of the rippled
sheets contain all-D amino acid residues. The designation of the capping peptide is followed by the ﬁgure number in the SI that corresponds to the
capped sheet.
a

As seen from tables 2−4, replacing the N−H’s of the
backbone and the Q with one or more methyls enhances the
ΔHint’s vs the same peptides without the methyls. However,
most of this enhancement comes from lower ΔEdist’s, rather
than better ΔEHB’s. Thus, like TLKIVW, they derive signiﬁcant
stabilization from their relatively low ΔEHB’s. Replacing the
backbone N−H’s with methyls on KYVIacKV for binding at the
bottom provides the exception. On the other hand, methylating
the N−H(s) on the Q-side chain for binding at the top
enhances both ΔHint and ΔEHB.
As already noted, many of the best interactions combine the
advantages of the H-bond to the Q’s with an AP interaction
between the cap and the sheet. These interactions can be
combined by reversing the order of the residues in the capping
peptide (VQIVYK−>KYVIQV) so that the Q’s remain adjacent
to each other on the interacting strands. Replacing the Q with
an aK on the capping peptide does not provide a large change
in the interactions. The ΔHint’s become slightly enhanced, and
the ΔEHB’s, slightly reduced for the P interactions; the reverse
occurs for AP from the bottom, and both are slightly reduced
for binding from the bottom. Nevertheless, the AP interactions
with KYVIaKV remain quite favorable for interaction at both
ends of the sheet (ΔHint by 3.6−4.2, and ΔEHB, by 1.8−2.3
kcal/mol). Solely on the basis of these ΔHint’s, at physiological
temperature, these should bind 20−1000 times more favorably
than the natural sequence. Except for KYVIaKV, all the
promising candidates listed in Table 2 can block the growth of
the VQIVYK amyloid from only one direction. Thus, one
would need a combination of two of these to eﬀectively stop

pleated interactions. Of the peptides that lack an H-bond to the
Q’s, TLKIVW has stronger ΔEHB’s than AAAAAA, with a
maximum of −48.1 for the AP interaction at the top and an
overall average 1.2 kcal/mol greater than AAAAAA for all eight
(four each with the normal and all-D residues) possible
interactions. The (all-D) TLKIVW reported by Eisenberg36
has rather favorable ΔHint’s (but not ΔEHB’s) for AP
interactions at both top and bottom. These can be found in
Table 3 with the other peptide caps that have favorable ΔHint’s
but not ΔEHB’s. They derive much of their binding aﬃnity from
the relatively low ΔEdist’s for the cap.
Several of the peptides with the most favorable interactions
(table 2) combine the H-bonding to the Q’s with an AP
interaction. Because the AP interaction with VQIVYK cannot
accommodate an H-bond between the Q’s, we accomplished
this by using KYVIQV, the reverse order of the amyloid
sequence. This peptide has signiﬁcantly stronger ΔHint’s and
ΔEHB’s for interactions with both the top and bottom. There is
no reason to expect these to arrest amyloid growth because a
normal VQIVYK should be capable of binding to the other side
of this peptide to extend the growth. Nevertheless, we found
that substituting an aK for Q resulted in larger ΔHini’s and
ΔEHB’s only slightly smaller. However, because the geometries
of the resulting sheets make further H-bonding by VQIVYK
extremely unfavorable, whether bound to the top or bottom of
the sheet, these might be useful for capping amyloid growth.
Replacing one or more of the H-bond acceptor N−H’s of the
backbone amides or that of the Q with a methyl (or other
substituent) would inhibit growth from one side.
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the growth. This renders KYVIaKV the most attractive
candidate for a model drug. Adding another VQIVYK to a
trimer capped with KYVIaKV at either end (illustrated in
Supporting Information Figures S63 and S64) is less favorable
than adding VQIVYK to a tetramer by 5.1 (top) and 2.9
(bottom) for ΔHint and 6.2 (top) and 3.9 (bottom) kcal/mol
for ΔEHB, which should be suﬃcient to prevent further growth
of the amyloid sheet.
The equilibrium between a growing amyloid and a peptidebased therapeutic agent depend upon the free energy diﬀerence
between the solid amyloid and the dissolved agent.
Furthermore, the kinetic of addition of the agent to the
amyloid will depend upon the concentration of the agent in
solution. To be eﬀective, both the thermodynamics and the
kinetics must be favorable for the process. If one were to design
a peptide to be used as a practical anti-Alzheimer’s medication
based upon the results of these calculations, one would need to
control the solubility of the peptide. To be eﬀective, the peptide
would have to be suﬃciently soluble to diﬀuse to the growing
tau amyloid and leave the solution, but not so soluble that it
would energetically prefer the solvated environment to binding
at the edge of the amyloid. A recent report that increasing the
histidine (H) content of peptides rich in Q reduces the extent
of aggregation of these peptides by increasing their solubility45
illustrates this eﬀect. Another common method of modulating
the solubilities of the peptide would be attaching the
polyethyleneglycol (PEG), which is not generally toxic. Because
the electronic substituent eﬀects are small and those on ΔEdist
are generally favorable, one might expect replacing one or more
N−H’s with some form of PEG would not adversely aﬀect the
binding interaction of the capping peptide.
We have not considered the possibility that the K’s might be
protonated in the amyloid because they would be adjacent to
each other and, thus, highly repulsive if completely protonated
in a low dielectric medium (the solid amyloid). The possibility
exists that the K’s might be protonated (or partially so), which
would require the presence of counterions (OH−, for example).
The stability of OH− in a solid would be less than in aqueous
solution and depends upon the proximity to the positive
charges. At this time, we do not have the means to evaluate this
possibility properly; however, we note that as a limitation of
this study.
Future work in this area might focus on combining the
aﬃnity of the all-D TLKIVW cap developed by Eisenberg36 with
a side chain that can increase the stability of the sheet by Hbonding to the Q side chains. This might be accomplished by
substituting Q or aK for L in that structure because L occupies
the position in register with the Q in the amyloid that would
allow for H-bond cooperativity to the cap.
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